• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有非转移性和非炎性乳腺癌的年轻女性预后是否较差?

Do younger women with non-metastatic and non-inflammatory breast carcinoma have poor prognosis?

作者信息

Mathew Aleyamma, Pandey Manoj, Rajan Balakrishnan

机构信息

Division of Epidemiology and Clinical Research, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.

出版信息

World J Surg Oncol. 2004 Jan 22;2:2. doi: 10.1186/1477-7819-2-2.

DOI:10.1186/1477-7819-2-2
PMID:14736343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC340386/
Abstract

BACKGROUND

Controversy abounds over whether breast cancer in younger women is more aggressive than those in older. The aim of the study was to assess the influence of age on long-term survival of women with breast carcinoma.

MATERIALS AND METHODS

Patients with non-metastatic and non-inflammatory invasive breast carcinoma treated at the Regional Cancer Centre, Trivandrum, Kerala, India during 1990-93 were divided into 4 age groups as < 40 years, 40-49, 50-59, and > 60 years. The overall survival (OS) for each age group was estimated using the Kaplan-Meier method in relation to the primary tumor (T) and the axillary node status (N). The OS of the various age groups were compared using the log-rank test. Hazard ratio and 95% confidence interval for each age group was estimated using Cox-regression model after adjusting for T and N.

RESULTS

Between 1990-1993, 1701 women (26%, <40 years) reported with non-metastatic and non-inflammatory invasive breast carcinoma. Overall survival (OS) of all the women was 52.6 % (standard error 1%) at 10 years. The OS for women with age < 40 years and with T3 and T4 disease status was 36.6% and 10.4% respectively and for those in 40-49 age group was 41.9% and 33.5%. The 10-year OS for women with node positive (N1) disease was 24.6% in < 40 years and 45.2% in the 40-49 age group (p = 0.0006). After adjusting for tumor and node stage the relative risk for death was 24% lower for women in 40-49 age group as compared to women <40 years of age.

CONCLUSION

Women under 40 years with T3/ T4 breast lesions and/or positive axillary nodes were found to have a significantly poorer survival.

摘要

背景

关于年轻女性乳腺癌是否比老年女性的更具侵袭性,存在诸多争议。本研究的目的是评估年龄对乳腺癌女性长期生存的影响。

材料与方法

1990 - 1993年期间在印度喀拉拉邦特里凡得琅地区癌症中心接受治疗的非转移性、非炎性浸润性乳腺癌患者被分为4个年龄组:<40岁、40 - 49岁、50 - 59岁和>60岁。使用Kaplan - Meier方法根据原发肿瘤(T)和腋窝淋巴结状态(N)估计每个年龄组的总生存期(OS)。使用对数秩检验比较各年龄组的OS。在对T和N进行校正后,使用Cox回归模型估计每个年龄组的风险比和95%置信区间。

结果

1990 - 1993年间,1701名女性(26%,<40岁)报告患有非转移性、非炎性浸润性乳腺癌。所有女性的10年总生存期(OS)为52.6%(标准误1%)。年龄<40岁且疾病状态为T3和T4的女性的OS分别为36.6%和10.4%,40 - 49岁年龄组的女性分别为41.9%和33.5%。淋巴结阳性(N1)疾病女性的10年OS在<40岁组为24.6%,在40 - 49岁年龄组为45.2%(p = 0.0006)。在对肿瘤和淋巴结分期进行校正后,40 - 49岁年龄组女性的死亡相对风险比<40岁的女性低24%。

结论

发现年龄<40岁且患有T3/T4乳腺病变和/或腋窝淋巴结阳性的女性生存情况明显较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/c414192da446/1477-7819-2-2-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/ff22cff55d2f/1477-7819-2-2-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/aa7f8397a50e/1477-7819-2-2-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/09cd280a15a0/1477-7819-2-2-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/8bcd617887c4/1477-7819-2-2-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/0b792034b904/1477-7819-2-2-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/8c6fab74872d/1477-7819-2-2-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/e681ff1b88d0/1477-7819-2-2-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/c414192da446/1477-7819-2-2-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/ff22cff55d2f/1477-7819-2-2-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/aa7f8397a50e/1477-7819-2-2-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/09cd280a15a0/1477-7819-2-2-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/8bcd617887c4/1477-7819-2-2-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/0b792034b904/1477-7819-2-2-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/8c6fab74872d/1477-7819-2-2-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/e681ff1b88d0/1477-7819-2-2-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0abe/340386/c414192da446/1477-7819-2-2-8.jpg

相似文献

1
Do younger women with non-metastatic and non-inflammatory breast carcinoma have poor prognosis?患有非转移性和非炎性乳腺癌的年轻女性预后是否较差?
World J Surg Oncol. 2004 Jan 22;2:2. doi: 10.1186/1477-7819-2-2.
2
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
3
Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.腋窝淋巴结转移阳性率可预测非转移性乳腺癌患者的生存率。
Acta Oncol. 2008;47(2):232-8. doi: 10.1080/02841860701678761.
4
Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival.浸润性乳腺癌腋窝淋巴结微转移:全国发病率及总生存数据
APMIS. 2007 Jul;115(7):828-37. doi: 10.1111/j.1600-0463.2007.apm_442.x.
5
[Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].[转移淋巴结比率在预测非小细胞肺癌患者预后中的价值]
Zhonghua Yi Xue Za Zhi. 2011 Jun 28;91(24):1682-6.
6
A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.对11400例纯黏液性乳腺癌病例进行长期随访的回顾性研究。
Breast Cancer Res Treat. 2008 Oct;111(3):541-7. doi: 10.1007/s10549-007-9809-z. Epub 2007 Nov 18.
7
Younger women with breast carcinoma have a poorer prognosis than older women.患有乳腺癌的年轻女性比年长女性的预后更差。
Cancer. 1996 Jan 1;77(1):97-103. doi: 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3.
8
Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.选择具有T1-T2肿瘤且腋窝淋巴结有1至3个阳性、保乳术后局部区域复发风险高的乳腺癌患者进行辅助放疗。
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1337-47. doi: 10.1016/j.ijrobp.2004.08.009.
9
Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis?对于初诊时即为 IV 期乳腺癌的女性,局部区域性肿瘤治疗能否改善其结局?
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):39-45. doi: 10.1016/j.ijrobp.2011.11.046. Epub 2012 Feb 11.
10
Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.极年轻激素受体阳性乳腺癌患者预后不良归因于他莫昔芬耐药:韩国全国生存数据——来自韩国乳腺癌协会的报告
J Clin Oncol. 2007 Jun 10;25(17):2360-8. doi: 10.1200/JCO.2006.10.3754. Epub 2007 May 21.

引用本文的文献

1
Burdens of Breast Cancer and Projections for 2030 Among Women in Asia: Findings from the 2021 Global Burden of Disease Study.亚洲女性乳腺癌负担及2030年预测:2021年全球疾病负担研究结果
Curr Oncol. 2025 May 1;32(5):267. doi: 10.3390/curroncol32050267.
2
Influence of depression on breast cancer treatment and survival: A Kentucky population-based study.抑郁对乳腺癌治疗和生存的影响:肯塔基州基于人群的研究。
Cancer. 2023 Jun 15;129(12):1821-1835. doi: 10.1002/cncr.34676. Epub 2023 Apr 17.
3
To Evaluate the Role of Positron Emission Tomography-Computerized Tomography in Initial Staging of Carcinoma Breast.

本文引用的文献

1
Factors influencing the effect of age on prognosis in breast cancer: population based study.影响年龄对乳腺癌预后作用的因素:基于人群的研究
BMJ. 2000 Feb 19;320(7233):474-8. doi: 10.1136/bmj.320.7233.474.
2
Age as a prognostic factor in breast cancer.
Anticancer Res. 1998 May-Jun;18(3B):1891-6.
3
Effect of age on the survival of breast cancer patients.年龄对乳腺癌患者生存率的影响。
Eur J Cancer. 1997 Mar;33(3):425-8. doi: 10.1016/s0959-8049(97)89017-x.
评估正电子发射断层扫描-计算机断层扫描在乳腺癌初始分期中的作用。
J Pharm Bioallied Sci. 2021 Nov;13(Suppl 2):S1354-S1359. doi: 10.4103/jpbs.jpbs_163_21. Epub 2021 Nov 10.
4
Effects of the number of removed lymph nodes on survival outcome in patients with sentinel node-negative breast cancer.前哨淋巴结阴性乳腺癌患者清扫淋巴结数目对生存结局的影响。
World J Surg Oncol. 2021 Oct 19;19(1):306. doi: 10.1186/s12957-021-02418-9.
5
First Comprehensive Report of Clinicopathological Profile of Breast Cancer from Bihar, India.印度比哈尔邦乳腺癌临床病理特征的首份综合报告。
Indian J Surg Oncol. 2021 Sep;12(3):598-602. doi: 10.1007/s13193-021-01404-7. Epub 2021 Aug 12.
6
Rising Incidence of Breast Cancer in the Young Fertile Indian Population-a Reality Check.印度年轻育龄人群中乳腺癌发病率上升——现实审视
Indian J Surg Oncol. 2018 Sep;9(3):296-299. doi: 10.1007/s13193-018-0800-4. Epub 2018 Jul 23.
7
Impact of p53 arg72pro SNP on Breast Cancer Risk in North Indian Population.p53基因第72位密码子精氨酸突变为脯氨酸的单核苷酸多态性对印度北部人群乳腺癌风险的影响。
Curr Genomics. 2018 Aug;19(5):395-410. doi: 10.2174/1389202919666171205104137.
8
Delays in Breast Cancer Detection and Treatment in Developing Countries.发展中国家乳腺癌检测与治疗的延误情况。
Breast Cancer (Auckl). 2018 Jan 8;12:1178223417752677. doi: 10.1177/1178223417752677. eCollection 2018.
9
Evolutionary aspects of non-metastatic breast cancer after primary treatment in a sub-Saharan African setting: a 16-year retrospective review at the Douala general hospital, Cameroon.撒哈拉以南非洲地区原发性治疗后非转移性乳腺癌的进化:喀麦隆杜阿拉综合医院 16 年回顾性研究。
BMC Cancer. 2018 Jan 5;18(1):32. doi: 10.1186/s12885-017-3984-z.
10
Correlation between cyclin D1 expression and standard clinicopathological variables in invasive breast cancer in Eastern India.印度东部浸润性乳腺癌中细胞周期蛋白D1表达与标准临床病理变量之间的相关性。
South Asian J Cancer. 2015 Oct-Dec;4(4):155-9. doi: 10.4103/2278-330X.175950.
4
Role of age as a prognostic factor in breast cancer.年龄作为乳腺癌预后因素的作用。
Surg Today. 1997;27(3):213-6. doi: 10.1007/BF00941647.
5
Younger women with breast carcinoma have a poorer prognosis than older women.患有乳腺癌的年轻女性比年长女性的预后更差。
Cancer. 1996 Jan 1;77(1):97-103. doi: 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3.
6
Breast cancer in young women.年轻女性乳腺癌
Surg Clin North Am. 1996 Apr;76(2):279-87. doi: 10.1016/s0039-6109(05)70439-4.
7
Survival of breast cancer patients from Piedmont, Italy.意大利皮埃蒙特地区乳腺癌患者的生存率。
Cancer Causes Control. 1993 May;4(3):209-15. doi: 10.1007/BF00051315.
8
Age does not predict breast cancer outcome.年龄无法预测乳腺癌的预后。
Arch Surg. 1994 May;129(5):483-7; discussion 487-8. doi: 10.1001/archsurg.1994.01420290029004.
9
Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer.I期或II期乳腺癌患者的年龄与肿瘤病理特征及预后的关系。
J Clin Oncol. 1994 May;12(5):888-94. doi: 10.1200/JCO.1994.12.5.888.
10
Age as prognostic factor in premenopausal breast carcinoma.
Lancet. 1993 Apr 24;341(8852):1039-43. doi: 10.1016/0140-6736(93)92407-k.